Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Immunological studies in hypersensitivity pneumopathies].

G Akoun1, J Cadranel, B Milleron

  • 1Centre de Pneumologie et de Réanimation Respiratoire, Hôpital Tenon, Paris.

Revue Des Maladies Respiratoires
|January 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Recommendations of French specialists on screening for lung cancer].

Revue des maladies respiratoires·2021
Same author

Potential lung cancer screening outcomes using different age and smoking thresholds in the ANRS-CO4 French Hospital Database on HIV cohort.

HIV medicine·2019
Same author

[IoNESCO trial: Immune neoajuvant therapy in early stage non-small cell lung cancer].

Revue des maladies respiratoires·2018
Same author

[Structuring the French thoracic oncology over the last 20 years].

Revue des maladies respiratoires·2017
Same author

[Current knowledge on perioperative treatments of non-small cell lung carcinomas].

Revue des maladies respiratoires·2017
Same author

Pazopanib or placebo in completely resected stage I NSCLC patients: results of the phase II IFCT-0703 trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2017
Same journal

[French version of the guidelines for connective tissue disease-associated ILD].

Revue des maladies respiratoires·2026
Same journal

[Pulmonary expression of an asymptomatic lysosomal storage disorder].

Revue des maladies respiratoires·2026
Same journal

[Factors associated with FEV1 evolution in cystic fibrosis patients treated by CFTR modulator tritherapy].

Revue des maladies respiratoires·2026
Same journal

[Subacute pulmonary coccidioidomycosis: A differential diagnosis of lung cancer].

Revue des maladies respiratoires·2026
Same journal

[Relevance of the ACT score in severe asthma with obesity: A pilot study].

Revue des maladies respiratoires·2026
Same journal

[Automated analysis of mandibular movements for the screening of obstructive sleep apnea].

Revue des maladies respiratoires·2026
See all related articles

Cell-mediated hypersensitivity tests and broncho-alveolar lavage analysis offer reliable diagnostic insights for hypersensitivity pneumonia. Cytotoxic lymphocyte activity is a key differentiator in patients versus exposed individuals.

Area of Science:

  • Immunology
  • Pulmonology
  • Pathophysiology

Context:

  • Hypersensitivity pneumonia diagnosis presents challenges due to unreliable immunological markers.
  • Traditional tests like skin tests and precipitating antibody searches often yield false positives in exposed individuals.

Purpose:

  • To evaluate the diagnostic utility of various immunological investigations in hypersensitivity pneumonia.
  • To identify reliable biomarkers for differentiating patients from asymptomatic exposed subjects.

Summary:

  • Cell-mediated hypersensitivity tests demonstrate higher reliability compared to skin tests and IgE searches.
  • Broncho-alveolar lavage analysis reveals an inverted T4:T8 lymphocyte ratio and lymphocyte activation in patients.
  • Distinct cytotoxic lymphocyte activity is observed exclusively in patients, not in asymptomatic exposed individuals.

Related Experiment Videos

  • Broncho-alveolar lavage coupled with provocation tests provides strong diagnostic evidence.

    • Impact:

    • Improved diagnostic accuracy for hypersensitivity pneumonia.
    • Identification of specific immunological markers for clinical and research applications.
    • Enhanced understanding of the pathophysiology of hypersensitivity pneumonia.